Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K C Anderson

Showing results (41-50 of 329) with videos related to

Pageof 33
Sort By:
Transfusion|September 1, 1993
Transfusion-associated graft-versus-host disease: scratching the surfaceR A Shivdasani, K C Anderson
Blood|June 15, 1997
A tribute to Jan Gosta WaldenströmR A Kyle, K C Anderson
Leukemia & Lymphoma|June 1, 1999
Risks, costs, and alternatives to platelet transfusionsI J Webb, K C Anderson
Immunology Today|May 8, 2000
Preparing the ground for vaccination against multiple myelomaF K Stevenson, K C Anderson
Cancer Journal (Sudbury, Mass.)|June 23, 2001
Allotransplantation for multiple myelomaE P Alyea, K C Anderson
Leukemia & Lymphoma|October 1, 1994
HLA homozygosity and shared HLA haplotypes in the development of transfusion-associated graft-versus-host diseaseR A Shivdasani, K C Anderson
The New England Journal of Medicine|August 2, 1990
Transfusion-associated graft-versus-host diseaseK C Anderson, H J Weinstein
Important Advances in Oncology|January 1, 1986
Bone marrow transplantation in the therapy of non-Hodgkin's lymphomasK C Anderson, L M Nadler
Hematology/Oncology Clinics of North America|April 1, 1990
The evolving role of bone marrow transplantation in the treatment of chronic myelogenous leukemiaR Delage, J Ritz, K C Anderson
British Journal of Cancer|October 19, 2006
A novel proteasome inhibitor NPI-0052 as an anticancer therapyD Chauhan, T Hideshima, K C Anderson
Pageof 33

Showing results (41-50 of 329) with videos related to

Sort By:
Pageof 33
Transfusion|September 1, 1993
Transfusion-associated graft-versus-host disease: scratching the surfaceR A Shivdasani, K C Anderson
Blood|June 15, 1997
A tribute to Jan Gosta WaldenströmR A Kyle, K C Anderson
Leukemia & Lymphoma|June 1, 1999
Risks, costs, and alternatives to platelet transfusionsI J Webb, K C Anderson
Immunology Today|May 8, 2000
Preparing the ground for vaccination against multiple myelomaF K Stevenson, K C Anderson
Cancer Journal (Sudbury, Mass.)|June 23, 2001
Allotransplantation for multiple myelomaE P Alyea, K C Anderson
Leukemia & Lymphoma|October 1, 1994
HLA homozygosity and shared HLA haplotypes in the development of transfusion-associated graft-versus-host diseaseR A Shivdasani, K C Anderson
The New England Journal of Medicine|August 2, 1990
Transfusion-associated graft-versus-host diseaseK C Anderson, H J Weinstein
Important Advances in Oncology|January 1, 1986
Bone marrow transplantation in the therapy of non-Hodgkin's lymphomasK C Anderson, L M Nadler
Hematology/Oncology Clinics of North America|April 1, 1990
The evolving role of bone marrow transplantation in the treatment of chronic myelogenous leukemiaR Delage, J Ritz, K C Anderson
British Journal of Cancer|October 19, 2006
A novel proteasome inhibitor NPI-0052 as an anticancer therapyD Chauhan, T Hideshima, K C Anderson
Pageof 33